Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Calibration of the Average Breathing Rate Measurement of the Cloud DX Pulsewave Health Monitor (PAD-2A) Device (CCV-3)

NCT04868630 is registered in ClinicalTrials.gov with Cardiovascular Research New Brunswick as lead sponsor.

NCT NCT04868630
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04868630 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Calibration of the Average Breathing Rate Measurement of the Cloud DX Pulsewave Health Monitor (PAD-2A) Device (CCV-3)
Lead sponsor
Cardiovascular Research New Brunswick
Phase
Observational
Overall status
Unknown status
Start date
September 10, 2021
Completion date
December 31, 2023
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

outpatients